Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
ILMN Form 4 activity by transaction type, last 90 days
Form 4 transaction type
Transactions
Shares
Total value
Open-market sale
69
2,061,850
$436.48M
Grant or award
9
44,608
Tax withholding / forfeiture
2
1,711
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ILMN insider transactions (Form 4)
124
99 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 1 of 3.
Footnote F1 (shares): Mr. Meister elected to receive 100% of his 2026 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the… Full note on SEC EDGAR
Footnote F1 (shares): Mr. Ullem elected to receive 100% of his 2026 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the… Full note on SEC EDGAR
Footnote F1 (shares): Grant of restricted stock units with 25% of the shares subject to the award vesting on each of the first, second, third and fourth anniversaries of the date of grant, subject to the awardee's continuing to be a service provider on such dates.
Footnote F2 (shares): Grant of restricted stock units shall vest as follows: 33.3% of the shares subject to the award shall vest on each of September 5, 2027, September 5, 2028, and September 5, 2029, subject to the awardee's continuing status as a service provider on such dates.
Footnote F3 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $212.42 to $213.41. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $213.42 to $214.02.
Footnote F5 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $214.80 to $215.77.
Footnote F6 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $215.81 to $216.80.
Footnote F7 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $216.81 to $217.78.
Footnote F8 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $217.86 to $218.85.
Footnote F9 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $218.88 to $219.87.
Footnote F10 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $219.88 to $220.85.
Footnote F11 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $220.88 to $221.66.
Footnote F12 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $217.00 to $217.84.
Footnote F13 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $218.00 to $218.99.
Footnote F14 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $219.00 to $219.56.
Footnote F3 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $224.77 to $225.76. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $225.77 to $226.75.
Footnote F5 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $226.78 to $226.80.
Footnote F6 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $224.09 to $225.08.
Footnote F7 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $225.09 to $226.08.
Footnote F8 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $226.09 to $226.95.
Footnote F9 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $227.09 to $227.50.
Footnote F10 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $226.04 to $227.03.
Footnote F11 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $227.04 to $228.03.
Footnote F12 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $228.04 to $229.03.
Footnote F13 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $229.04 to $230.03.
Footnote F14 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $230.04 to $231.03.
Footnote F15 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $231.04 to $231.71.
Footnote F3 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $201.59 to $202.58. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and… Full note on SEC EDGAR
Footnote F4 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $202.59 to $203.58.
Footnote F5 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $203.65 to $204.61.
Footnote F6 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $204.72 to $205.11.
Footnote F7 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $207.01 to $207.91.
Footnote F8 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $208.02 to $209.01.
Footnote F9 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $209.11 to $210.10.
Footnote F10 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $210.11 to $211.09.
Footnote F11 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $211.14 to $212.13.
Footnote F12 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $212.14 to $213.12.
Footnote F13 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $213.14 to $214.13.
Footnote F14 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $214.14 to $215.11.
Footnote F15 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $215.14 to $216.13.
Footnote F16 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $216.14 to $217.13.
Footnote F17 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $217.14 to $218.13.
Footnote F18 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $218.14 to $219.13.
Footnote F19 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $219.15 to $220.00.
Footnote F20 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $210.01 to $210.99.
Footnote F21 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $211.06 to $212.04.
Footnote F22 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $212.06 to $213.05.
Footnote F23 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $213.07 to $214.06.
Footnote F24 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $214.07 to $215.06.
Footnote F25 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $215.07 to $216.06.
Footnote F26 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $216.07 to $217.06.
Footnote F27 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $217.07 to $218.05.
Footnote F28 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $218.07 to $219.06.
Footnote F29 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $219.07 to $220.06.
Footnote F30 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $220.07 to $220.43.
Footnote F1 (shares): Grant of restricted stock units with 25% of the shares subject to the award vesting on each of the first, second, third and fourth anniversaries of the date of grant, subject to the awardee's continuing to be a service provider on such dates.
Footnote F3 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $196.00 to $196.99. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and… Full note on SEC EDGAR
Footnote F5 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $197.00 to $197.99.
Footnote F6 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $198.00 to $198.98.
Footnote F7 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $199.00 to $199.96.
Footnote F8 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $200.00 to $200.99.
Footnote F9 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $201.00 to $201.99.
Footnote F10 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $202.00 to $202.99.
Footnote F11 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $203.00 to $203.44.
Footnote F12 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $197.60 to $198.59.
Footnote F13 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $198.60 to $199.59.
Footnote F14 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $199.60 to $200.59.
Footnote F15 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $200.60 to $201.59.
Footnote F16 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $201.60 to $202.58.
Footnote F17 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $202.60 to $203.50.
Footnote F1 (shares): Mr. Meister elected to receive 100% of his 2026 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the… Full note on SEC EDGAR
Footnote F1 (shares): Mr. Ullem elected to receive 100% of his 2026 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the… Full note on SEC EDGAR
Footnote F1 (shares): Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's… Full note on SEC EDGAR
Footnote F1 (price): Weighted average sale price representing 290 shares sold ranging from $161.30 to $162.19 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Footnote F2 (price): Weighted average sale price representing 374 shares sold ranging from $162.31 to $163.25 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Footnote F3 (price): Weighted average sale price representing 78 shares sold ranging from $163.35 to $163.36 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Footnote F1 (price): Weighted average sale price representing 176 shares sold ranging from $160.30 to $161.24 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Footnote F2 (price): Weighted average sale price representing 318 shares sold ranging from $161.65 to $162.26 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Footnote F3 (price): Weighted average sale price representing 290 shares sold ranging from $162.66 to $163.33 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Footnote F3 (price): As previously reported, the Corvex Funds had entered into equity swaps that represented an aggregate economic long-side exposure comparable to a notional interest in 368,744 shares of common stock of the Issuer. Under the terms of the swaps, the value to be received or paid upon… Full note on SEC EDGAR
Footnote F5 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $155.85 to $156.84. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and… Full note on SEC EDGAR
Footnote F6 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $156.85 to $157.84.
Footnote F7 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $157.85 to $158.77.
Footnote F8 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $159.05 to $160.04.
Footnote F9 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $160.05 to $161.03.
Footnote F10 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $161.05 to $162.03.
Footnote F11 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $162.05 to $162.98.
Footnote F12 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $163.13 to $164.09.
Footnote F13 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $164.14 to $165.09.
Footnote F14 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $162.19 to $163.16.
Footnote F15 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $163.19 to $164.18.
Footnote F16 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $164.19 to $165.18.
Footnote F17 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $165.20 to $165.43.
Footnote F18 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $162.00 to $162.99.
Footnote F19 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $163.00 to $163.99.
Footnote F20 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $164.00 to $164.99.
Footnote F21 (price): The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $165.00 to $165.95.
Footnote F1 (shares): Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's… Full note on SEC EDGAR
Footnote F1 (shares): Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's… Full note on SEC EDGAR
Footnote F1 (shares): Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's… Full note on SEC EDGAR
Footnote F1 (shares): Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's… Full note on SEC EDGAR
Footnote F1 (shares): Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's… Full note on SEC EDGAR
Footnote F1 (shares): Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest the date prior to the annual meeting of the company's stockholders in the year of the award, provided, in each case, that the awardee continues to serve as a director on… Full note on SEC EDGAR
Footnote F1 (shares): Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest the date prior to the annual meeting of the company's stockholders in the year of the award, provided, in each case, that the awardee continues to serve as a director on… Full note on SEC EDGAR
Footnote F1 (shares): Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's… Full note on SEC EDGAR
An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
ILLUMINA, INC. (ILMN) had 12 insider filings in the last 90 days, with the most recent on 2026-10-07. The full record for ILMN runs to 99 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ILMN stock?
No insider purchases of ILMN were filed in the last 90 days. 10 purchases are on record for this company.
How many insiders are selling ILMN stock?
69 insider sales of ILMN were filed in the last 90 days, totaling $436.48M.
Where can I see ILMN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ILMN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
House of Representatives Periodic Transaction Reports from 2024. Senate filings are not included yet. The full history of ILMN beside its insider purchases is in the Congress Tracker.
Keith A. Meister - DirectorOpen-market sale$12.26M
Scott B. Ullem - Director
Julie Ann Coletti - Officer
Steven Barnard - Officer
Scott Gottlieb - Director
Gilbert Ray Cisneros, Jr.Democrat, CA-31
